Rapid deployment technology versus conventional sutured bioprostheses in aortic valve replacement

Area of Science:

• Cardiovascular Surgery
• Medical Devices
• Interventional Cardiology

Background:

• Conventional sutured aortic valve replacement (cAVR) is standard for aortic stenosis.
• Rapid deployment aortic valve prostheses (RDAVR) offer potential benefits but are less commonly used.
• Limited randomized data exists comparing RDAVR and cAVR.

Purpose of the Study:

• To compare the safety and efficacy of RDAVR versus cAVR for treating aortic stenosis.
• To synthesize available evidence through a systematic meta-analysis.
• To evaluate key clinical outcomes and procedural metrics.

Main Methods:

• Systematic literature search of PubMed, OVID, and MEDLINE.
• Inclusion of 35 comparative studies (1 randomized, 1 registry, 6 propensity-matched, 28 observational).
• Meta-analysis of data from 10,381 patients (3686 RDAVR, 6310 cAVR).

Main Results:

• No significant differences in operative mortality, stroke, or bleeding between RDAVR and cAVR.
• RDAVR demonstrated significantly reduced cardiopulmonary bypass and cross-clamp times.
• RDAVR was associated with shorter intensive care unit stays.
• Increased risk of pacemaker insertion and midterm paravalvular leak (PVL) observed with RDAVR.
• RDAVR showed more favorable effective orifice area and transvalvular gradient.

Conclusions:

• RDAVR offers advantages in reduced operative time and enhanced recovery.
• Increased risks of pacemaker insertion and midterm PVL with RDAVR require careful consideration.
• Further research may be needed to mitigate RDAVR-associated risks.